267 related articles for article (PubMed ID: 33098770)
21. Apigenin and related compounds stimulate adult neurogenesis. Mars, Inc., the Salk Institute for Biological Studies: WO2008147483.
Taupin P
Expert Opin Ther Pat; 2009 Apr; 19(4):523-7. PubMed ID: 19441930
[TBL] [Abstract][Full Text] [Related]
22. Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease.
Strupp BJ; Powers BE; Velazquez R; Ash JA; Kelley CM; Alldred MJ; Strawderman M; Caudill MA; Mufson EJ; Ginsberg SD
Curr Alzheimer Res; 2016; 13(1):97-106. PubMed ID: 26391046
[TBL] [Abstract][Full Text] [Related]
23. Pre- and post-natal melatonin administration partially regulates brain oxidative stress but does not improve cognitive or histological alterations in the Ts65Dn mouse model of Down syndrome.
Corrales A; Parisotto EB; Vidal V; García-Cerro S; Lantigua S; Diego M; Wilhem Filho D; Sanchez-Barceló EJ; Martínez-Cué C; Rueda N
Behav Brain Res; 2017 Sep; 334():142-154. PubMed ID: 28743603
[TBL] [Abstract][Full Text] [Related]
24. [Molecular Mechanism Underlying Abnormal Differentiation of Neural Progenitor Cells in the Developing Down Syndrome Brain].
Kurabayashi N; Sanada K
Yakugaku Zasshi; 2017; 137(7):795-800. PubMed ID: 28674289
[TBL] [Abstract][Full Text] [Related]
25. Gene and protein expression profiles of JAK-STAT signalling pathway in the developing brain of the Ts1Cje down syndrome mouse model.
Lee HC; Md Yusof HH; Leong MP; Zainal Abidin S; Seth EA; Hewitt CA; Vidyadaran S; Nordin N; Scott HS; Cheah PS; Ling KH
Int J Neurosci; 2019 Sep; 129(9):871-881. PubMed ID: 30775947
[No Abstract] [Full Text] [Related]
26. Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome.
Siarey RJ; Villar AJ; Epstein CJ; Galdzicki Z
Neuropharmacology; 2005 Jul; 49(1):122-8. PubMed ID: 15992587
[TBL] [Abstract][Full Text] [Related]
27. Indomethacin promotes survival of new neurons in the adult murine hippocampus accompanied by anti-inflammatory effects following MPTP-induced dopamine depletion.
Hain EG; Sparenberg M; Rasińska J; Klein C; Akyüz L; Steiner B
J Neuroinflammation; 2018 May; 15(1):162. PubMed ID: 29803225
[TBL] [Abstract][Full Text] [Related]
28. Increased lipid peroxidation in Down's syndrome mouse models.
Ishihara K; Amano K; Takaki E; Ebrahim AS; Shimohata A; Shibazaki N; Inoue I; Takaki M; Ueda Y; Sago H; Epstein CJ; Yamakawa K
J Neurochem; 2009 Sep; 110(6):1965-76. PubMed ID: 19645748
[TBL] [Abstract][Full Text] [Related]
29. Copper accumulation in the brain causes the elevation of oxidative stress and less anxious behavior in Ts1Cje mice, a model of Down syndrome.
Ishihara K; Kawashita E; Shimizu R; Nagasawa K; Yasui H; Sago H; Yamakawa K; Akiba S
Free Radic Biol Med; 2019 Apr; 134():248-259. PubMed ID: 30660502
[TBL] [Abstract][Full Text] [Related]
30. Duloxetine prevents the effects of prenatal stress on depressive-like and anxiety-like behavior and hippocampal expression of pro-inflammatory cytokines in adult male offspring rats.
Zhang X; Wang Q; Wang Y; Hu J; Jiang H; Cheng W; Ma Y; Liu M; Sun A; Zhang X; Li X
Int J Dev Neurosci; 2016 Dec; 55():41-48. PubMed ID: 27637928
[TBL] [Abstract][Full Text] [Related]
31. Apigenin attenuates hippocampal oxidative events, inflammation and pathological alterations in rats fed high fat, fructose diet.
Kalivarathan J; Chandrasekaran SP; Kalaivanan K; Ramachandran V; Carani Venkatraman A
Biomed Pharmacother; 2017 May; 89():323-331. PubMed ID: 28237914
[TBL] [Abstract][Full Text] [Related]
32. Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice.
Nakano-Kobayashi A; Awaya T; Kii I; Sumida Y; Okuno Y; Yoshida S; Sumida T; Inoue H; Hosoya T; Hagiwara M
Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10268-10273. PubMed ID: 28874550
[TBL] [Abstract][Full Text] [Related]
33. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.
Guidi S; Stagni F; Bianchi P; Ciani E; Giacomini A; De Franceschi M; Moldrich R; Kurniawan N; Mardon K; Giuliani A; Calzà L; Bartesaghi R
Brain; 2014 Feb; 137(Pt 2):380-401. PubMed ID: 24334313
[TBL] [Abstract][Full Text] [Related]
34. Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development.
Laffaire J; Rivals I; Dauphinot L; Pasteau F; Wehrle R; Larrat B; Vitalis T; Moldrich RX; Rossier J; Sinkus R; Herault Y; Dusart I; Potier MC
BMC Genomics; 2009 Mar; 10():138. PubMed ID: 19331679
[TBL] [Abstract][Full Text] [Related]
35. Melatonin attenuates 5-fluorouracil-induced spatial memory and hippocampal neurogenesis impairment in adult rats.
Sirichoat A; Suwannakot K; Chaisawang P; Pannangrong W; Aranarochana A; Wigmore P; Welbat JU
Life Sci; 2020 May; 248():117468. PubMed ID: 32105705
[TBL] [Abstract][Full Text] [Related]
36. Object recognition memory is conserved in Ts1Cje, a mouse model of Down syndrome.
Fernandez F; Garner CC
Neurosci Lett; 2007 Jun; 421(2):137-41. PubMed ID: 17566652
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional disruptions in Down syndrome: a case study in the Ts1Cje mouse cerebellum during post-natal development.
Potier MC; Rivals I; Mercier G; Ettwiller L; Moldrich RX; Laffaire J; Personnaz L; Rossier J; Dauphinot L
J Neurochem; 2006 Apr; 97 Suppl 1():104-9. PubMed ID: 16635258
[TBL] [Abstract][Full Text] [Related]
38. Chronic Melatonin Administration Reduced Oxidative Damage and Cellular Senescence in the Hippocampus of a Mouse Model of Down Syndrome.
Parisotto EB; Vidal V; García-Cerro S; Lantigua S; Wilhelm Filho D; Sanchez-Barceló EJ; Martínez-Cué C; Rueda N
Neurochem Res; 2016 Nov; 41(11):2904-2913. PubMed ID: 27450081
[TBL] [Abstract][Full Text] [Related]
39. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
[TBL] [Abstract][Full Text] [Related]
40. Disruption of neurogenesis and cortical development in transgenic mice misexpressing Olig2, a gene in the Down syndrome critical region.
Liu W; Zhou H; Liu L; Zhao C; Deng Y; Chen L; Wu L; Mandrycky N; McNabb CT; Peng Y; Fuchs PN; Lu J; Sheen V; Qiu M; Mao M; Lu QR
Neurobiol Dis; 2015 May; 77():106-16. PubMed ID: 25747816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
